Tatva Chintan Pharma IPO (Tatva Chintan Pharma IPO) Detail
About the Tatva Chintan Pharma Chem Ltd IPO
The company was incorporated as ‘Tatva Chintan Pharma Chem Private Limited’ pursuant to a certificate of incorporation dated June 12, 1996 issued by the Registrar of Companies, Gujarat and Dadra & Nagar Haveli at Ahmedabad (“RoC”). Thereafter, pursuant to the conversion of the Company to a public limited company, the name of the Company was changed to ‘Tatva Chintan Pharma Chem Limited’, and a fresh certificate of incorporation dated February 26, 2021 was issued to the Company by the RoC.
Registered Office: Plot No. 502 / 17, GIDC Estate, Ankleshwar, Bharuch, Gujarat – 393 002, India; Telephone: +91 75730 46951 / +91 75730 46952
Corporate Office: Plot No. 353, Makarpura GIDC, Vadodara, Gujarat – 390 010, India
Contact Person: Apurva Dubey, Company Secretary and Compliance Officer; Telephone: + 91 75748 48533 / +91 75748 48534; E-mail: cs@tatvachintan.com
Website: www.tatvachintan.com; Corporate Identity Number: U24232GJ1996PLC029894
Promoters of Tatva Chintan Pharma Chem Ltd IPO
Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Shekhar Rasiklal Somani
Company Financials
Summary of Restated Consolidated Financial Information
For the year/period ended (₹ in Million)
| Particulars | |||
|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 |
| Profit After Tax | 522.62 | 377.89 | 205.43 |
| Total Asset | 3,148.03 | 2,489.38 | 1,875.08 |
Tatva Chintan Pharma Chem Ltd – IPO Details
IPO Details
| Issue Open Date | 16 Jul 2021 |
| Issue Close Date | 20 Jul 2021 |
| Issue Type | Book Build |
| Face Value | ₹ 10.00 per equity share |
| IPO/Issue Price | ₹ 1073 to ₹ 1083 per equity share |
| Market Lot | 13 Shares |
| Min Order Quantity | 13 Shares |
| Listing At | BSE, NSE |
IPO/ Issue Time Line [Tentative]
Issue Open Date
Issue Close Date
Basis of Allotment Date
Initiation of Refunds
Credit of Shares to Demat Account
IPO Listing Date
Objects of the Issue/Offer
Funding the capital expenditure requirements for expansion of Dahej Manufacturing facility:
Funding capital expenditure requirements to upgrade R&D facilities in Vadodra and
General Corporate purposes.
When the Tatva Chintan Pharma IPO will Open?
When the Tatva Chintan Pharma IPO will close?
What is the lot size of the Tatva Chintan Pharma IPO?
Also read other articles @ EduTaxTuber
